1. Açık Erişim@BUU

Browsing by Author Piratvisuth, Teerha

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
2005-10Factors associated with sustained virologic response 1 year after treatment with peginterferon alfa-2A (40KD) (PEGASYS (R)) monotherapy for HBEAG-negative chronic hepatitis BPatrick, Marcellin; Ferruccio, Bonino; Lau, Grace; Patrizia, Farci; Yurdaydın, Cihan; Piratvisuth, Teerha; Jin, Rui; Hadziyannis, Stephanos; Lu, Zhi-Meng; Popescu, Matei; Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı.; Gürel, Selim
2009-10A finite course of peginterferon alfa-2a results in inactive chronic hepatitis b and hbsag clearance 5 years post-treatment in patients with hbeag-negative disease: Baseline characteristics and predictive factors of long-term responseMarcellin, Patrick; Piratvisuth, Teerha; Brunetto, Maurizia; Bonino, Ferruccio; Farci, Patrizia; Yurdaydın, Cihan; Kapprell, Hans Peter; Messinger, Diethelm; Batrla, Richard; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı.; Gürel, Selim
2009Increasing rates of hbsag clearance and seroconversion in patients with hbeag-negative disease treated with peginterferon alfa-2a +/- lamivudine: Results of 5-year post-treatment follow upMarcellin, Patrick; Piratvisuth, Teerha; Brunetto, Maurizia; Bonino, F.; Lau, George; Farci, Patrizia; Yurdaydın, Cihan; Wu, J.; Popescu, Matei; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı.; Gürel, Selim
2006The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatmentMarcellin, Patrick; Bonino, Ferruccio; Lau, George; Farci, Patrizia; Yurdaydin, C.; Piratvisuth, Teerha; Jin, R.; Hadziyannis, Stephanos J.; Lu, Zhimeng; Popescu, Madalina; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı.; Gürel, Selim
2018-05-22No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis BWei, Lai; Wedemeyer, Heiner; Liaw, Yun-Fan; Chan, Henry Lik-Yuen; Piratvisuth, Teerha; Marcellin, Patrick; Jia, Jidong; Tan, Deming; Chow, Wan-Cheng; Brunetto, Maurizia R.; Diago, Moises; Morozov, Viacheslav; He, Hua; Zhu, Yonghong; Wat, Cynthia; Surujbally, Bernadette; Thompson, Alexander J.; Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı.; Gürel, Selim; HLH-8209-2023; 7003706434
2004-09-16Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis BMarcellin, Patrick; Lau, George; Bonino, Ferruccio; Farci, Patrizia; Hadziyannis, Stephanos; Jin, R.; Lu, ZM; Piratvisuth, Teerha; Germanidis, Georgios; Yurtaydin, Cihan; Moises, Diago; Mingyang, Lai; Button, P.; Pluck, Nigel; Bursa Uludağ Üniversitesi/Tıp Fakültesi.; Gurel, Selim
2006-10Suppression of HBV DNA in patients with HBeAg-negative CHB treated with peginterferon alfa-2A (40KD) +/- lamivudine: 2-year follow-up resultsMarcellin, Patrick; Bonino, Ferruccio; Lau, George; Farci, Patrizia; Yurdaydin, Cihan; Piratvisuth, Teerha; Luo, Kangxian; Hadziyannis, Stephanos J.; Wang, Yuming; Popescu, Matei; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.; Gürel, Selim
2009-06Sustained response of Hepatitis B e Antigen-Negative patients 3 years after treatment with Peginterferon Alfa-2aYurdaydın, Cihan; Marcellin, Patrick; Bonino, Ferruccio; Lau, George; Farci, Patrizia; Piratvisuth, Teerha; Jin, Rui; Lu, Zhi-Meng; Wu, Jian; Popescu, Matei; Hadziyannis, Stephanos; Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı.; Gürel, Selim; 7003706434
Showing results 1 to 8 of 8